药物防治减压病的研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Drug prevention and treatment of decompression sickness: research progress
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    减压病是由于环境压力下降速度过快或幅度过大,由溶解于体内的惰性气体在血管或组织中形成气泡而引起的一系列症状和体征,严重时可以威胁生命安全。目前,再加压吸氧治疗是减压病的主要治疗措施,但并不能满足重症减压病的治疗需求,仍需药物辅助治疗。防治减压病的可选药物有限,尚未发现特效药物。多年来,学界不断探索用于治疗减压病的药物,如抗血小板药、抗炎药、抗氧化药、气泡消融药及中药等。其中,应用中药防治减压病可能会是减压病防治领域研究的新方向。本文综述了20世纪80年代至今减压病防治药物的研究进展。

    Abstract:

    Decompression sickness (DCS) is a series of symptoms and signs caused by bubbles in blood vessels or tissue with dissolved inert gas due to the rapid or excessive reduction of environmental pressure, which can threaten life safety in severe case. At present, recompression oxygen inhalation therapy is the main treatment of DCS, but it cannot meet the treatment needs of severe DCS, and drug adjuvant therapy is still needed. However, the optional drugs for the prevention and treatment of DCS are limited, and no specific drugs have been found. Over the years, scholars have been constantly exploring drugs for the DCS therapy, such as antiplatelet drugs, anti-inflammatory drugs, antioxidant drugs, bubble ablation drugs, and traditional Chinese medicine. Among them, traditional Chinese medicine may be a new direction in the field of prevention and treatment of DCS. This paper reviews the research progress of drug treatment of DCS since 1980s.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-06-22
  • 最后修改日期:2022-12-22
  • 录用日期:
  • 在线发布日期: 2024-01-27
  • 出版日期: 2024-01-20
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭